About Optho Pharma
Optho Pharma is a company based in Prayagraj (India). The company has 22 employees. Optho Pharma offers products and services including Lubricating Eye Drops and Ophthalmic Ointments.
- Headquarter Prayagraj, India
- Employees 22
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Legal Name Optho Pharma Pvt. Ltd
- Date of Incorporation 15 Oct, 2018
- Jurisdiction Allahabad, Uttar Pradesh, India
- Annual Revenue₹7.37 Cr
FY 2024 · -9% YoY
- Net Profit₹33.9 Lakh
FY 2024 · 5% margin
- EBITDA₹50.9 Lakh
FY 2024 · 7% margin
- Employee Count22
Associated legal entities of Optho Pharma
Optho Pharma operates through Optho Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Optho Pharma Private Limited CIN U33100UP2018PTC109224 | Active | 15 Oct 2018 | Allahabad, Uttar Pradesh | ₹7.4 Cr | 22 | 2 | View details |
Products & Services of Optho Pharma
Optho Pharma offers a comprehensive portfolio of products and services, including Lubricating Eye Drops and Ophthalmic Ointments.
These eye drops are utilized for advanced dry eye relief and are formulated to be preservative-free.
Ointments are employed as advanced, sterile formulations for various eye care needs.
Board of directors of Optho Pharma Private Limited (Optho Pharma)
Optho Pharma Private Limited is the primary company behind Optho Pharma. The board of Optho Pharma Private Limited currently have 2 directors; the longest-serving is Rohit Agarwal, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rohit Agarwal DIN 08257242 | Director | 15 Oct 2018 | 7 yrs 11 mo | Optho Pharma Private Limited |
| Rajesh Agarwal DIN 00245357 | Director | 15 Oct 2018 | 7 yrs 11 mo | Optho Pharma Private Limited |
Financials of Optho Pharma
Figures of Optho Pharma Private Limited, the primary company behind Optho Pharma, for FY 2024. Revenue was ₹7.37 Cr (-9% year on year). Net profit was ₹33.9 Lakh (5% margin). EBITDA was ₹50.9 Lakh (7% margin). Revenue has grown at a compounded annual rate of -3% over three years and +7% over five years.
- ₹7.37 CrRevenue · FY 2024 · -9% YoY
- ₹33.9 LakhNet profit · 5% margin
- ₹50.9 LakhEBITDA · 7% margin
- ₹41.4 LakhPaid-up capital
- 22Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Optho Pharma Private Limited are on its company page.
Detailed financial statements for Optho Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Optho Pharma
10 companies that operate in the same segment as Optho Pharma (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Optho Pharma
Optho Pharma is headquartered in Prayagraj, India. It is registered at Prayagraj, Uttar Pradesh, India.
Optho Pharma has 22 employees.
The primary company behind Optho Pharma, Optho Pharma Private Limited, reported revenue of βΉ7.37 Cr for FY 2024, down 9% year on year.
Optho Pharma has been recognized for its involvement in manufacturing specialized eye care products, ranging from general to specific therapeutic needs, for over 55 years. Products are distributed across India and beyond, with a strong emphasis placed on both prevention and cure in eye care. Research and innovation are conducted through state-of-the-art facilities, ensuring rigorous quality control and clinical trials. Diversification into other healthcare segments has been achieved, maintaining a commitment to superior, tailored formulations.
Optho Pharma offers Lubricating Eye Drops and Ophthalmic Ointments.
Optho Pharma operates through Optho Pharma Private Limited.
The legal entities of Optho Pharma currently have 2 directors, including Rohit Agarwal, Rajesh Agarwal.
